{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:42:00Z","timestamp":1778028120671,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1124\/jpet.107.135681","type":"journal-article","created":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T00:58:45Z","timestamp":1206493125000},"page":"818-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice"],"prefix":"10.1016","volume":"325","author":[{"given":"Magnus","family":"Baumh\u00e4kel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Schlimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kansu","family":"B\u00fcy\u00fckaf\u015far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Arikan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.135681_bib1","doi-asserted-by":"crossref","unstructured":"Baumh\u00e4kel M and B\u00f6hm M (2007) Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract 61: 361-366.","DOI":"10.1111\/j.1742-1241.2006.01274.x"},{"key":"10.1124\/jpet.107.135681_bib2","doi-asserted-by":"crossref","unstructured":"Baumh\u00e4kel M, Werner N, B\u00f6hm M, and Nickenig G (2006) Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease. Eur Heart J 27: 2184-2188.","DOI":"10.1093\/eurheartj\/ehl202"},{"key":"10.1124\/jpet.107.135681_bib3","doi-asserted-by":"crossref","unstructured":"Beere PA, Glagov S, and Zarins CK (1984) Retarding effect of lowered heart rate on coronary atherosclerosis. Science 226: 180-182.","DOI":"10.1126\/science.6484569"},{"key":"10.1124\/jpet.107.135681_bib4","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M, Baumh\u00e4kel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, and Koon T (2007) Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND). Am Heart J 154: 94-101.","DOI":"10.1016\/j.ahj.2007.03.024"},{"key":"10.1124\/jpet.107.135681_bib5","doi-asserted-by":"crossref","unstructured":"Boydak B, Nalbantgil S, Fici F, Nalbantgil I, Zoghi M, Ozerkan F, Tengiz I, Ercan E, Yilmaz H, Yoket U, et al. (2005) A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Investig 25: 409-416.","DOI":"10.2165\/00044011-200525060-00006"},{"key":"10.1124\/jpet.107.135681_bib6","doi-asserted-by":"crossref","unstructured":"Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, and Engelmann U (2000) Epidemiology of erectile dysfunction: results of the `Cologne Male Survey.\u2019 Int J Impot Res 12: 305-311.","DOI":"10.1038\/sj.ijir.3900622"},{"key":"10.1124\/jpet.107.135681_bib7","doi-asserted-by":"crossref","unstructured":"Brixius K, Middeke M, Lichtenthal A, Jahn E, and Schwinger RH (2007) Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 34: 327-331.","DOI":"10.1111\/j.1440-1681.2007.04551.x"},{"key":"10.1124\/jpet.107.135681_bib8","doi-asserted-by":"crossref","unstructured":"B\u00fcy\u00fckaf\u015far K and Un I (2003) Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol 472: 235-238.","DOI":"10.1016\/S0014-2999(03)01905-8"},{"key":"10.1124\/jpet.107.135681_bib9","doi-asserted-by":"crossref","unstructured":"de Groot AA, Mathy MJ, van Zwieten PA, and Peters SL (2004) Antioxidant activity of nebivolol in the rat aorta. J Cardiovasc Pharmacol 43: 148-153.","DOI":"10.1097\/00005344-200401000-00022"},{"key":"10.1124\/jpet.107.135681_bib10","doi-asserted-by":"crossref","unstructured":"Duesing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2: 29-34.","DOI":"10.1080\/08038020310021967"},{"key":"10.1124\/jpet.107.135681_bib11","doi-asserted-by":"crossref","unstructured":"Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, and McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151: 54-61.","DOI":"10.1016\/S0022-5347(17)34871-1"},{"key":"10.1124\/jpet.107.135681_bib12","doi-asserted-by":"crossref","unstructured":"Fogari R, Zoppi A, Corradi L, Mugellini A, Poletti L, and Lusardi P (1998) Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11: 1244-1247.","DOI":"10.1016\/S0895-7061(98)00139-3"},{"key":"10.1124\/jpet.107.135681_bib13","doi-asserted-by":"crossref","unstructured":"Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, and Corradi L (2001) Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 14: 27-31.","DOI":"10.1016\/S0895-7061(00)01214-0"},{"key":"10.1124\/jpet.107.135681_bib14","doi-asserted-by":"crossref","unstructured":"Franzen D, Metha A, Seifert N, Braun M, and Hopp HW (2001) Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int J Impot Res 13: 348-351.","DOI":"10.1038\/sj.ijir.3900787"},{"key":"10.1124\/jpet.107.135681_bib15","doi-asserted-by":"crossref","unstructured":"Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, and Elmer PJ (1997) Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 29: 8-14.","DOI":"10.1161\/01.HYP.29.1.8"},{"key":"10.1124\/jpet.107.135681_bib16","doi-asserted-by":"crossref","unstructured":"Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, and Krumholz HM (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288: 351-357.","DOI":"10.1001\/jama.288.3.351"},{"key":"10.1124\/jpet.107.135681_bib17","doi-asserted-by":"crossref","unstructured":"Laufs U, Wassmann S, Czech T, Munzel T, Eisenhauer M, B\u00f6hm M, and Nickenig G (2005) Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol 25: 809-814.","DOI":"10.1161\/01.ATV.0000158311.24443.af"},{"key":"10.1124\/jpet.107.135681_bib18","doi-asserted-by":"crossref","unstructured":"Maack C, Cremers B, Flesch M, Hoper A, Sudkamp M, and B\u00f6hm M (2000) Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Br J Pharmacol 130: 1131-1139.","DOI":"10.1038\/sj.bjp.0703400"},{"key":"10.1124\/jpet.107.135681_bib19","doi-asserted-by":"crossref","unstructured":"Maack C, Tyroller S, Schnabel P, Cremers B, Dabew E, Sudkamp M, and B\u00f6hm M (2001) Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium. Br J Pharmacol 132: 1817-1826.","DOI":"10.1038\/sj.bjp.0703992"},{"key":"10.1124\/jpet.107.135681_bib20","unstructured":"Modebe O (1990) Erectile failure among medical clinic patients. Afr J Med Med Sci 19: 259-264."},{"key":"10.1124\/jpet.107.135681_bib21","unstructured":"National Institutes of Health Consensus Statement (1992) Impotence 10: 1."},{"key":"10.1124\/jpet.107.135681_bib22","doi-asserted-by":"crossref","unstructured":"Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, et al. (2006) Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48: 677-684.","DOI":"10.1161\/01.HYP.0000239207.82326.29"},{"key":"10.1124\/jpet.107.135681_bib23","doi-asserted-by":"crossref","unstructured":"Reidenbach C, Schwinger RH, Steinritz D, Kehe K, Thiermann H, Klotz T, Sommer F, Bloch W, and Brixius K (2007) Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum. Life Sci 80: 2421-2427.","DOI":"10.1016\/j.lfs.2007.04.016"},{"key":"10.1124\/jpet.107.135681_bib24","doi-asserted-by":"crossref","unstructured":"Rosenkranz S and Erdmann E (2001) [Interaction between sildenafil and antihypertensive drugs: what is evidence-based?]. Dtsch Med Wochenschr 126: 1144-1149.","DOI":"10.1055\/s-2001-17743"},{"key":"10.1124\/jpet.107.135681_bib25","doi-asserted-by":"crossref","unstructured":"Selvan PS, Gowda KV, Mandal U, Solomon WD, and Pal TK (2007) Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 858: 143-150.","DOI":"10.1016\/j.jchromb.2007.08.016"},{"key":"10.1124\/jpet.107.135681_bib26","doi-asserted-by":"crossref","unstructured":"Siebert CD, Hansicke A, and Nagel T (2008) Stereochemical comparison of nebivolol with other beta-blockers. Chirality 20: 103-109.","DOI":"10.1002\/chir.20509"},{"key":"10.1124\/jpet.107.135681_bib27","doi-asserted-by":"crossref","unstructured":"Silvestri A, Galetta P, Cerquetani E, Marazzi G, Patrizi R, Fini M, and Rosano GM (2003) Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 24: 1928-1932.","DOI":"10.1016\/j.ehj.2003.08.016"},{"key":"10.1124\/jpet.107.135681_bib28","doi-asserted-by":"crossref","unstructured":"Toblli JE, Cao G, Casas G, and Mazza ON (2006) In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Am J Hypertens 19: 1226-1232.","DOI":"10.1016\/j.amjhyper.2006.05.016"},{"key":"10.1124\/jpet.107.135681_bib29","doi-asserted-by":"crossref","unstructured":"Wassmann S, Czech T, van Eickels M, Fleming I, B\u00f6hm M, and Nickenig G (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice. Circulation 110: 3062-3067.","DOI":"10.1161\/01.CIR.0000137970.47771.AF"},{"key":"10.1124\/jpet.107.135681_bib30","doi-asserted-by":"crossref","unstructured":"Wolf SC, Sauter G, Preyer M, Poerner T, Kempf VA, Risler T, and Brehm BR (2007) Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol. Cell Physiol Biochem 19: 129-136.","DOI":"10.1159\/000099201"},{"key":"10.1124\/jpet.107.135681_bib31","doi-asserted-by":"crossref","unstructured":"Yavuzgil O, Altay B, Zoghi M, Gurgun C, Kayikcioglu M, and Kultursay H (2005) Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 103: 19-26.","DOI":"10.1016\/j.ijcard.2004.07.004"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.135681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:38:38Z","timestamp":1740004718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524344532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0022356524344532"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.135681","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.135681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}